RxDoctor Payments Data

James Gahagan, DO

Family Medicine · Pensacola, FLNPI 1063733368

Payments from drug & device makers

$167in general payments, 2019–2025

Across 13 payments — averaging $12.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$56
  • Lilly USA, LLC$26
  • AstraZeneca$25
  • Merck$23
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$13
  • Pfizer$13
  • plus $11 from 1 others

What the payments were for

  • Food & beverage$167100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$167 in reported general payments places this provider in the 30th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$140,859
Medicare patients
403
Services billed
1,238

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin147$190,816
Trelegy ElliptaFluticasone/Umeclidin/Vilanter182$184,999
OzempicSemaglutide103$123,492
TrulicityDulaglutide58$87,483
EliquisApixaban55$62,284
MounjaroTirzepatide55$61,313
LinzessLinaclotide61$57,445
JanuviaSitagliptin Phosphate19$20,869
RybelsusSemaglutide13$17,794
JanumetSitagliptin Phos/Metformin Hcl26$14,631
Janumet XrSitagliptin Phos/Metformin Hcl12$10,288
Rosuvastatin Calcium588$7,910
Dutasteride-TamsulosinDutasteride/Tamsulosin Hcl33$7,902
Gabapentin378$6,834
Albuterol Sulfate HfaAlbuterol Sulfate221$6,793

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$26$148,796113 claims
Novo NordiskOzempic, Rybelsus$56$141,286116 claims
PfizerEliquis, Premarin$13$67,70267 claims
MerckJanuvia, Janumet, Janumet Xr$23$45,78857 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →